Ko Hanai
Overview
Explore the profile of Ko Hanai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori T, Hanai K, Yamamoto Y, Yoshida N, Murata H, Nakagami T
Clin Exp Nephrol
. 2024 Dec;
PMID: 39724496
Background: Whether diabetic retinopathy (DR) can predict kidney disease progression in individuals with diabetes remains unclear. Furthermore, there are only a limited number of studies investigating the association between DR...
2.
Yoshida N, Hanai K, Babazono T
Clin Exp Nephrol
. 2024 Apr;
28(9):894-901.
PMID: 38613740
Background: Limited direct comparative studies exist in terms of the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is) on the kidney outcomes in Japanese individuals with...
3.
Mori T, Nyumura I, Hanai K, Shinozaki T, Babazono T
Diabetol Int
. 2024 Mar;
15(2):278-289.
PMID: 38524933
This single-center observational cohort study aimed to assess the potential benefits of simultaneous pancreas and kidney transplantation (SPK) in terms of mortality and kidney graft outcomes in Japanese individuals with...
4.
Babazono T, Hanai K, Yokoyama Y, Uchiyama K
Clin Exp Nephrol
. 2023 Aug;
27(12):1001-1009.
PMID: 37606804
Background: The National Kidney Foundation recently proposed a ≥ 30% decrease in urinary albumin-to-creatinine ratio (UACR) over 0.5-2 years as a surrogate endpoint for chronic kidney disease (CKD) progression in...
5.
Yokoyama Y, Hanai K, Mori T, Yamamoto Y, Yoshida N, Murata H, et al.
Clin Exp Nephrol
. 2023 Feb;
27(5):465-472.
PMID: 36840900
Background: It remains unclear whether urinary albumin changes can predict subsequent kidney disease progression in people with diabetes. Methods: This retrospective cohort study included 4570 Japanese adults with type 2...
6.
Hanai K, Mori T, Yamamoto Y, Yoshida N, Murata H, Babazono T
Diabetes Care
. 2022 Nov;
46(1):183-189.
PMID: 36399781
Objective: To elucidate the association of glomerular filtration rate (GFR) at baseline with subsequent progression of albuminuria in individuals with type 2 diabetes. Research Design And Methods: This was a...
7.
Sugawara Y, Hirakawa Y, Mise K, Kashiwabara K, Hanai K, Yamaguchi S, et al.
Biomark Med
. 2022 May;
16(10):759-770.
PMID: 35583042
It is important to identify additional prognostic factors for diabetic kidney disease. Baseline levels of ten cytokines (APRIL/TNFSF13, BAFF/TNFSF13B, chitinase 3-like 1, LIGHT/TNFSF14, TWEAK/TNFSF12, gp130/sIL-6Rβ, sCD163, sIL-6Rα, sTNF-R1, sTNF-R2) were...
8.
Kameda Y, Saeki T, Hanai K, Suzuki Y, Uchigata Y, Babazono T, et al.
J Clin Med
. 2021 Nov;
10(22).
PMID: 34830589
Chronic kidney disease (CKD) is a well-known risk factor for postoperative complications in several surgical fields. However, although prevalent among diabetic candidates for vitrectomy, the effect of CKD on vitrectomy...
9.
Yamamoto Y, Hanai K, Mori T, Yokoyama Y, Yoshida N, Murata H, et al.
Diabetologia
. 2021 Nov;
65(1):234-245.
PMID: 34739552
Aim/hypothesis: It remains unclear whether people with diabetes exhibiting non-albuminuric kidney insufficiency have higher risk of kidney function decline and mortality compared with those exhibiting preserved kidney function without albuminuria....
10.
Yoshida N, Hanai K, Murata H, Uchigata Y, Babazono T
Diabetes Res Clin Pract
. 2020 Oct;
172:108519.
PMID: 33096189
Aims: To examine the association of dipstick hematuria with kidney function and albuminuria in patients with type 2 diabetes (T2D). Methods: A total of 7,945 patients with T2D were studied....